Preparation and In-vitro Evaluation of Controlled Release PLGA Microparticles Containing Triptoreline

Triptoreline is a potent agonist of luteinizing hormone-releasing hormone, currently used in the treatment of prostatic cancer where therapy may be required over months or years. Frequent injection of drug decreases patients’ compliance. The present study describes the formulation of a sustained rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahboubian, Alireza, Hashemein, Seyyed Kazem, Moghadam, Shadi, Atyabi, Fatemeh, Dinarvand, Rassoul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870060/
https://www.ncbi.nlm.nih.gov/pubmed/24381601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870060/
https://www.ncbi.nlm.nih.gov/pubmed/24381601

Ejemplares similares